Cannabis Bioscience International Holdings (CBIH) Non-Current Debt (2023 - 2026)
Cannabis Bioscience International Holdings' (CBIH) quarterly Non-Current Debt came in at $249500.0 in Q1 2026, little changed year-on-year from $249501.0 in Q1 2025, and little changed quarter-over-quarter from $249500.0 in Q4 2025.
Cannabis Bioscience International Holdings (CBIH) Non-Current Debt (2023 - 2026) Analysis & Trends
Cannabis Bioscience International Holdings has disclosed Non-Current Debt across 4 years of filings, most recently posting $249500.0 for Q1 2026.
- Non-Current Debt for Q1 2026 came in at $249500.0, changed 0.0% year-over-year; the trailing twelve-month figure through Feb 2026 was $249500.0 (changed 0.0% YoY), and the FY2025 annual result was $249500.0, changed 0.06% from the prior year.
- Non-Current Debt came in at $249500.0 for Q1 2026 at Cannabis Bioscience International Holdings, roughly flat from $249500.0 in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $249501.0 in Q1 2025 to a low of $249361.0 in Q2 2024.
- The 4-year median for Non-Current Debt is $249500.0 (2023), against an average of $249487.5.
- Across the five-year window, Non-Current Debt dropped 0.06% in 2024 and advanced 0.06% in 2025, its largest moves.
- Cannabis Bioscience International Holdings' Non-Current Debt stood at $249500.0 in 2023, then changed by 0.0% to $249500.0 in 2024, then changed by 0.0% to $249500.0 in 2025, then changed by 0.0% to $249500.0 in 2026.
- The last three Non-Current Debt figures came in at $249500.0 (Q1 2026), $249500.0 (Q4 2025), and $249500.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 14.02 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 9.05 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 3.92 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.48 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 569.60 Mn |
| 10 | Cannabis Bioscience International Holdings | - | - | 8,160.00 | 249,500.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 249,500.00 |
| Feb 28, 2026 | 249,500.00 |
| Nov 30, 2025 | 249,500.00 |
| Nov 30, 2025 | 249,500.00 |
| Aug 31, 2025 | 249,500.00 |
| Aug 31, 2025 | 249,500.00 |
| May 31, 2025 | 249,500.00 |
| May 31, 2025 | 249,500.00 |
| Feb 28, 2025 | 249,501.00 |
| Feb 28, 2025 | 249,501.00 |
| Nov 30, 2024 | 249,500.00 |
| Nov 30, 2024 | 249,500.00 |
| Aug 31, 2024 | 249,500.00 |
| Aug 31, 2024 | 249,500.00 |
| May 31, 2024 | 249,361.00 |
| May 31, 2024 | 249,361.00 |
| Feb 29, 2024 | 249,500.00 |
| Feb 29, 2024 | 249,500.00 |
| Nov 30, 2023 | 249,500.00 |
| Nov 30, 2023 | 249,500.00 |